메뉴 건너뛰기




Volumn 15, Issue 7, 1997, Pages 2559-2563

Ifosfamide- and cisplatin-containing chemotherapy as first-line salvage therapy in germ cell tumors: Response and survival

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; IFOSFAMIDE;

EID: 0030814035     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1997.15.7.2559     Document Type: Article
Times cited : (166)

References (19)
  • 1
    • 0027513298 scopus 로고
    • Randomized trial of etoposide and cisplatin versus etoposide and carboplatin in patients with good-risk germ cell tumors: A multiinstitutional study
    • Bajorin DF, Sarosdy MF, Pfister DG, et al: Randomized trial of etoposide and cisplatin versus etoposide and carboplatin in patients with good-risk germ cell tumors: A multiinstitutional study. J Clin Oncol 11:598-606, 1993
    • (1993) J Clin Oncol , vol.11 , pp. 598-606
    • Bajorin, D.F.1    Sarosdy, M.F.2    Pfister, D.G.3
  • 2
    • 0023195303 scopus 로고
    • Treatment of disseminated germ-cell tumors with cisplatin, bleomycin, and either vinblastine or etoposide
    • Williams SD, Birch R, Einhorn LH, et al: Treatment of disseminated germ-cell tumors with cisplatin, bleomycin, and either vinblastine or etoposide. N Engl J Med 316:1435-1440, 1987
    • (1987) N Engl J Med , vol.316 , pp. 1435-1440
    • Williams, S.D.1    Birch, R.2    Einhorn, L.H.3
  • 3
    • 0025875021 scopus 로고
    • Randomized study of cisplatin dose intensity in poor-risk germ cell tumors: A Southeastern Cancer Study Group and Southwest Oncology Group protocol
    • Nichols CR, Williams SD, Loehrer PJ, et al: Randomized study of cisplatin dose intensity in poor-risk germ cell tumors: A Southeastern Cancer Study Group and Southwest Oncology Group protocol. J Clin Oncol 9:1163-1172, 1991
    • (1991) J Clin Oncol , vol.9 , pp. 1163-1172
    • Nichols, C.R.1    Williams, S.D.2    Loehrer, P.J.3
  • 4
    • 0025613902 scopus 로고
    • The role of ifosfamide plus cisplatin-based chemotherapy as salvage therapy for patients with refractory germ cell tumors
    • Motzer RJ, Cooper K, Geller NL, et al: The role of ifosfamide plus cisplatin-based chemotherapy as salvage therapy for patients with refractory germ cell tumors. Cancer 66:2476-2481, 1990
    • (1990) Cancer , vol.66 , pp. 2476-2481
    • Motzer, R.J.1    Cooper, K.2    Geller, N.L.3
  • 5
    • 0027057141 scopus 로고
    • Ifosfamide-based chemotherapy for patients with resistant germ cell tumors: The Memorial Sloan-Kettering Cancer Center experience
    • Motzer RJ, Bajorin DF, Vlamis V, et al: Ifosfamide-based chemotherapy for patients with resistant germ cell tumors: The Memorial Sloan-Kettering Cancer Center experience. Semin Oncol 19:8-12, 1992
    • (1992) Semin Oncol , vol.19 , pp. 8-12
    • Motzer, R.J.1    Bajorin, D.F.2    Vlamis, V.3
  • 6
    • 0023695848 scopus 로고
    • Salvage therapy in recurrent germ cell cancer: Ifosfamide and cisplatin plus either vinblastine or etoposide
    • Loehrer PJ, Lauer R, Roth BJ, et al: Salvage therapy in recurrent germ cell cancer: Ifosfamide and cisplatin plus either vinblastine or etoposide. Ann Intern Med 109:540-546, 1988
    • (1988) Ann Intern Med , vol.109 , pp. 540-546
    • Loehrer, P.J.1    Lauer, R.2    Roth, B.J.3
  • 7
    • 0029877985 scopus 로고    scopus 로고
    • Cisplatin and ifosfamide with either vinblastine or etoposide as salvage therapy for refractory or relapsing germ cell tumor patients
    • Farhat F, Culine S, Theodore C, et al: Cisplatin and ifosfamide with either vinblastine or etoposide as salvage therapy for refractory or relapsing germ cell tumor patients. Cancer 77:1193-1197, 1996
    • (1996) Cancer , vol.77 , pp. 1193-1197
    • Farhat, F.1    Culine, S.2    Theodore, C.3
  • 8
    • 0007259603 scopus 로고    scopus 로고
    • Long term followup of second line chemotherapy with vinblastine, ifosfamide and cisplatin in disseminated germ cell tumors
    • abstr
    • Einhorn LH, Weathers T, Loehrer P, et al: Long term followup of second line chemotherapy with vinblastine, ifosfamide and cisplatin in disseminated germ cell tumors. Proc Am Soc Clin Oncol 15:240, 1996 (abstr)
    • (1996) Proc Am Soc Clin Oncol , vol.15 , pp. 240
    • Einhorn, L.H.1    Weathers, T.2    Loehrer, P.3
  • 9
    • 0026504386 scopus 로고
    • Modified cisplatin, etoposide (or vinblastine) and ifosfamide salvage therapy for male germ cell tumors. Long-term results
    • Pizzocaro G, Salvioni R, Piva L, et al: Modified cisplatin, etoposide (or vinblastine) and ifosfamide salvage therapy for male germ cell tumors. Long-term results. Ann Oncol 3:211-216, 1992
    • (1992) Ann Oncol , vol.3 , pp. 211-216
    • Pizzocaro, G.1    Salvioni, R.2    Piva, L.3
  • 10
    • 0000560759 scopus 로고
    • Phase III study of cisplatin, etoposide and bleomycin (PVP16B) or etoposide, ifosfamide and cisplatin (VIP) in advanced stage germ cell tumors: An intergroup trial
    • abstr
    • Nichols CR, Loehrer PJ, Einhorn LH, et al: Phase III study of cisplatin, etoposide and bleomycin (PVP16B) or etoposide, ifosfamide and cisplatin (VIP) in advanced stage germ cell tumors: An intergroup trial. Proc Am Soc Clin Oncol 14:239, 1995 (abstr)
    • (1995) Proc Am Soc Clin Oncol , vol.14 , pp. 239
    • Nichols, C.R.1    Loehrer, P.J.2    Einhorn, L.H.3
  • 11
    • 0026459668 scopus 로고
    • High-dose chemotherapy for resistant germ cell tumors: Recent advances and future directions
    • Motzer RJ, Bosl GJ: High-dose chemotherapy for resistant germ cell tumors: Recent advances and future directions. J Natl Cancer Inst 84:1703-1709, 1992
    • (1992) J Natl Cancer Inst , vol.84 , pp. 1703-1709
    • Motzer, R.J.1    Bosl, G.J.2
  • 12
    • 0028896184 scopus 로고
    • Recombinant human granulocyte-macrophage colony-stimulating factor as an adjunct to conventional-dose ifosfamide-based chemotherapy for patients with advanced or relapsed germ cell tumors: A randomized trial
    • Bajorin DF, Nichols CR, Schmoll H, et al: Recombinant human granulocyte-macrophage colony-stimulating factor as an adjunct to conventional-dose ifosfamide-based chemotherapy for patients with advanced or relapsed germ cell tumors: A randomized trial. J Clin Oncol 13:79-86, 1995
    • (1995) J Clin Oncol , vol.13 , pp. 79-86
    • Bajorin, D.F.1    Nichols, C.R.2    Schmoll, H.3
  • 13
    • 0026087605 scopus 로고
    • Salvage chemotherapy for patients with germ cell tumors. the Memorial Sloan-Kettering Cancer Center experience (1979-1989)
    • Motzer RJ, Geller NL, Tan CC, et al: Salvage chemotherapy for patients with germ cell tumors. The Memorial Sloan-Kettering Cancer Center experience (1979-1989). Cancer 67:1305-1310, 1991
    • (1991) Cancer , vol.67 , pp. 1305-1310
    • Motzer, R.J.1    Geller, N.L.2    Tan, C.C.3
  • 14
    • 0028860147 scopus 로고
    • Importance of bleomycin in favorable-prognosis disseminated germ cell tumors: An Eastern Cooperative Oncology Group trial
    • Loehrer P, Johnson D, Elson P, et al: Importance of bleomycin in favorable-prognosis disseminated germ cell tumors: An Eastern Cooperative Oncology Group trial. J Clin Oncol 13:470-476, 1995
    • (1995) J Clin Oncol , vol.13 , pp. 470-476
    • Loehrer, P.1    Johnson, D.2    Elson, P.3
  • 15
    • 0029737635 scopus 로고    scopus 로고
    • Selecting patients with cisplatin-resistant germ cell tumors for high-dose chemotherapy
    • Motzer RJ: Selecting patients with cisplatin-resistant germ cell tumors for high-dose chemotherapy. J Clin Oncol 14:2625-2626, 1996
    • (1996) J Clin Oncol , vol.14 , pp. 2625-2626
    • Motzer, R.J.1
  • 16
    • 0029928705 scopus 로고    scopus 로고
    • High-dose carboplatin, etoposide, and cyclophosphamide for patients with refractory germ cell tumors: Treatment results and prognostic factors for survival and toxicity
    • Motzer RJ, Mazumdar M, Bosl GJ, et al: High-dose carboplatin, etoposide, and cyclophosphamide for patients with refractory germ cell tumors: Treatment results and prognostic factors for survival and toxicity. J Clin Oncol 14:1098-1105, 1996
    • (1996) J Clin Oncol , vol.14 , pp. 1098-1105
    • Motzer, R.J.1    Mazumdar, M.2    Bosl, G.J.3
  • 17
    • 0343889015 scopus 로고
    • Tandem autotransplantation for initial relapse of germ cell cancer
    • abstr
    • Broun ER, Gize G, Nichols CR, et al: Tandem autotransplantation for initial relapse of germ cell cancer. Proc Am Soc Clin Oncol 14:243, 1995 (abstr)
    • (1995) Proc Am Soc Clin Oncol , vol.14 , pp. 243
    • Broun, E.R.1    Gize, G.2    Nichols, C.R.3
  • 18
    • 0027996483 scopus 로고
    • Phase II trial of paclitaxel shows antitumor activity in patients with previously treated germ cell tumors
    • Motzer RJ, Bajorin DF, Schwartz LH, et al: Phase II trial of paclitaxel shows antitumor activity in patients with previously treated germ cell tumors. J Clin Oncol 12:2277-2283, 1994
    • (1994) J Clin Oncol , vol.12 , pp. 2277-2283
    • Motzer, R.J.1    Bajorin, D.F.2    Schwartz, L.H.3
  • 19
    • 0028033791 scopus 로고
    • Preliminary results of a phase I/II trial of paclitaxel in patients with relapsed or cisplatin-refractory testicular cancer
    • Bokemeyer C, Schmoll H, Natt F, et al: Preliminary results of a phase I/II trial of paclitaxel in patients with relapsed or cisplatin-refractory testicular cancer. J Cancer Res Clin Oncol 120:754-757, 1994
    • (1994) J Cancer Res Clin Oncol , vol.120 , pp. 754-757
    • Bokemeyer, C.1    Schmoll, H.2    Natt, F.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.